Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Distribution, channel and commercial infrastructure

SectorREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Distribution, channel and commercial infrastructure

Products and services that make supplier offerings available to business buyers through intermediaries and market-access infrastructure. Includes authorised distributors, specialty sales forces, value-added resellers, group purchasing organisations and contract distributors, plus supply-chain, logistics and commercial-support services. Excludes care delivery and clinical outsourcing.

Market size
$71.8B
$71.8B · 2025 · Triangulated
Growth
+12.6%
$104B by 2034
Attractiveness
75 /100
for B2B sellers
Evidence
Low confidence
1 source · Triangulated
Level
Sector
Segmented by
Product or service
Buyers
Medical-device, diagnostic, software and life-science vendors
Value chain
Downstream
Maturity
Growth
Structure
Fragmented
Buying triggers
  • New manufacturer market-entry programmes
  • Provider tenders and framework renewals
  • Digitisation of procurement workflows
  • Supply-chain disruption or local-stock mandates
Pains
  • Fragmented local market access
  • Complex product configuration and training
  • Inventory and demand-planning complexity
  • Inconsistent commercial execution across territories
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability3
Growth4
Growth drivers
  • Digital procurement and e-commerce adoption
  • Manufacturer expansion into fragmented geographies
  • Provider consolidation and supply-reliability pressure
  • Growth in connected and digitally enabled medtech
Headwinds
  • Margin pressure from provider and payer consolidation
  • Working-capital and inventory-carrying cost
  • Regulatory, customs and authorisation complexity
  • Cybersecurity and integration risks in digital channels
Trends
  • Shift from transactional fulfilment to value-added services
  • Digital procurement portals and integrated inventory management
  • Local stockholding by distributors
  • Consolidation toward fewer strategic suppliers

Submarkets 4

Split by channel.

Submarket75/100

Specialty sales and clinical support organisations

Dedicated field sales, contract sales and clinical-support personnel that reach specialised clinical buyers and support product adoption.

$25.9B
Medical-device, diagnostic, software and life-science vendors
Low confidenceOpen
Submarket75/100

Authorised distributors and value-added resellers

Intermediaries that hold manufacturer authorisation to sell, hold inventory, configure and support products in defined territories.

$23.3B
Medical-device, diagnostic, software and life-science vendors
Low confidenceOpen
Submarket75/100

Supply-chain, logistics and commercial support

Warehousing, distribution management, logistics, demand planning and commercial operations services that connect manufacturers with business buyers.

$16.5B
Medical-device, diagnostic, software and life-science vendors
Low confidenceOpen

How this was sized

$71.8B · 2025 · Triangulated

Triangulated: published top-down figure $51700M covers a narrower scope than the bottom-up sum of 4 segments ($71780M); the bottom-up sum is used and the top-down figure is the low end. Global digital medtech distribution revenue pool of USD 51,700M in 2025, forecast to reach USD 103,800M by 2034 at a 12.6% CAGR. Scope covers technology-enabled distribution and commercial fulfilment of medical devices, diagnostics, surgical products, consumables and connected health technologies, including B2B e-commerce and digital procurement portals. This is used as the primary sector proxy because it is the only source aligned to medtech-specific channel revenue rather than total pharmaceutical distribution or gross product value.

Sources

Alongside it in Healthtech & medtech

// Sell into Distribution, channel and commercial infrastructure

AOS finds the biggest accounts in this sector with a reason to talk now, maps their buying centre and prepares the outreach for your approval.